|
1
|
Tisdale MJ: Biology of cachexia. J Natl
Cancer Inst. 89:1763–1773. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Argilés JM, Busquets S, Stemmler B and
Lopez-Soriano FJ: Cancer cachexia: Understanding the molecular
basis. Nat Rev Cancer. 14:754–762. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gannavarapu BS, Lau SKM, Carter K, Cannon
NA, Gao A, Ahn C, Meyer JJ, Sher DJ, Jatoi A, Infante R and Iyengar
P: Prevalence and survival impact of pretreatment cancer-associated
weight loss: A tool for guiding early palliative care. J Oncol
Pract. 14:e238–e250. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gilmore LA, Olaechea S, Gilmore BW,
Gannavarapu BS, Alvarez CM, Ahn C, Iyengar P and Infante RE: A
preponderance of gastrointestinal cancer patients transition into
cachexia syndrome. J Cahexia Sarcopenia Muscle. 13:2920–2931. 2022.
View Article : Google Scholar
|
|
5
|
Fearon K, Strasser F, Anker SD, Bosaeus I,
Bruera E, Fainsinger RL, Jatoi A, Loprinzi C, MacDonald N,
Mantovani G, et al: Definition and classification of cancer
cachexia: An international consensus. Lancet Oncol. 12:489–495.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Norton JA, Shamberger R, Stein TP, Milne
GWA and Brennan MF: The influence of tumor-bearing on protein
metabolism in the rat. J Surg Res. 30:456–462. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Smith KL and Tisdale MJ: Increased protein
degradation and decreased protein synthesis in skeletal muscle
during cancer cachexia. Br J Cancer. 67:680–685. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Martin A, Gallot YS and Freyssenet D:
Molecular mechanisms of cancer cachexia-related loss of skeletal
muscle mass: Data analysis from preclinical and clinical studies. J
Cachexia Sarcopenia Muscle. 14:1150–1167. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Acharyya S, Ladner KJ, Nelson LL, Damrauer
J, Reiser PJ, Swoap S and Guttridge DC: Cancer cachexia is
regulated by selective targeting of skeletal muscle gene products.
J Clin Invest. 114:370–378. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cai D, Frantz JD, Tawa NE Jr, Melendez PA,
Oh BC, Lidov HGW, Hasselgren PO, Frontera WR, Lee J, Glass DJ and
Shoelson SE: IKKbeta/NF-kappaB activation causes severe muscle
wasting in mice. Cell. 119:285–298. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Paul PK, Gupta SK, Bhatnagar S, Panguluri
SK, Darnay BG, Choi Y and Kumar A: Targeted ablation of TRAF6
inhibits skeletal muscle wasting in mice. J Cell Biol.
191:1395–1411. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cao Z, Zhao K, Jose I, Hoogenraad NJ and
Osellame LD: Biomarkers for cancer cachexia: A mini review. Int J
Mol Sci. 22:45012021. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gallagher IJ, Stephens NA, MacDonald AJ,
Skipworth RJE, Husi H, Greig CA, Ross JA, Timmons JA and Fearon
KCH: Suppression of skeletal muscle turnover in cancer cachexia:
Evidence from the transcriptome in sequential human muscle
biopsies. Clin Cancer Res. 18:2817–2827. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bonneto A, Penna F, Aversa Z, Mercantini
P, Baccino FM, Costelli P, Ziparo V, Lucia S, Fanelli FR and
Muscaritoli M: Early changes of muscle insulin-like growth factor-1
and myostatin gene expression in gastric cancer patients. Muscle
Nerve. 48:387–392. 2013. View Article : Google Scholar
|
|
15
|
D'orland C, Marzetti E, François S,
Lorenzi M, Conti V, Stasio ED, Rosa F, Brunelli S, Doglietto GB,
Pacelli F and Bossola M: Gastric cancer does not affect the
expression of atrophy-related genes in human skeletal muscle.
Muscle Nerve. 49:528–533. 2014. View Article : Google Scholar
|
|
16
|
Talbert EE and Guttridge DC: Impaired
regeneration: A role for the muscle microenvironment in cancer
cachexia. Semin Cell Dev Biol. 54:82–91. 2016. View Article : Google Scholar
|
|
17
|
Talbert EE, Cuitino MC, Landner KJ,
Rajasekerea PV, Siebert M, Shakya R, Leone GW, Ostrowski MC, Paleo
B, Weisleder N, et al: Modeling human cancer-induced cachexia. Cell
Rep. 28:1612–1622.e4. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Arneson PC and Doles JD: Impaired muscle
regeneration in cancer-associated cachexia. Trends in Cancer.
5:579–582. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Penna F, Costamagna D, Fanzani A, Bonelli
G, Baccino FM and Costelli P: Muscle wasting and impaired
myogenesis in tumor bearing mice are prevented by ERK inhibition.
PLoS One. 5:e136042010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ramamoorthy S, Donohue M and Buck M:
Decreased Jun-D expression in muscle wasting of human cachexia. Am
J Physiol Endocrinol Metab. 297:E392–E401. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hawke TJ and Garry DJ: Myogenic satellite
cells: Physiology to molecular biology. J Appl Physiol (1985).
91:534–551. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hollenberg SM, Cheng PF and Weintraub H:
Use of a conditional MyoD transcription factor in studies of MyoD
trans-activation and muscle determination. Proc Natl Acad Sci USA.
90:8028–8032. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Berkes CA and Tapscott SJ: MyoD and the
transcriptional control of myogenesis. Semin Cell Dev Biol.
16:585–595. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang Q, Vashisht AA, O'Rourke J, Corbel
SY, Moran R, Romero A, Miraglia L, Zhang J, Durrant E, Schmedt C,
et al: The microprotein Minion controls cell fusion and muscle
formation. Nat Commun. 8:156642017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ganassi M, Badodi S, Quiroga HPO, Zammit
PS, Hinits Y and Hughes SM: Myogenin promotes myocyte fusion to
balance fibre number and size. Nat Commun. 9:42322018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Dey BK, Gagan J, Yan Z and Dutta A:
miR-26a is required for skeletal muscle differentiation and
regeneration in mice. Genes Dev. 26:2180–2191. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Agarwal S, Cholok D, Loder S, Li J,
Breuler C, Chung MT, Sung HH, Ranganathan K, Habbouche J, Drake J,
et al: mTOR inhibition and BMP signaling act synergistically to
reduce muscle fibrosis and improve myofiber regeneration. JCI
Insight. 1:e898052016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Benezra R, Davis RL, Lockshon D, Turner DL
and Weintraud H: The protein Id: A negative regulator of
helix-loop-helix DNA binding proteins. Cell. 61:49–59. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Jen Y, Weintraub H and Benezra R:
Overexpression of Id protein inhibits the muscle differentiation
program: In vivo association of Id with E2A proteins. Genes Dev.
6:1466–1479. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Clever JL, Sakai Y, Wang RA and Schneider
DB: Inefficient skeletal muscle repair in inhibitor of
differentiation knockout mice suggests a crucial role for BMP
signaling during adult muscle regeneration. Am J Cell Physiol.
298:C1087–C1099. 2010. View Article : Google Scholar
|
|
31
|
Winbanks CE, Chen JL, Qian H, Liu Y,
Bernardo B, Beyer C, Watt KI, Thomson RE, Connor T, Turner BJ, et
al: The bone morphogenetic protein axis is a positive regulator of
skeletal muscle mass. J Cell Biol. 203:345–357. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hogan BL: Bone morphogenetic proteins:
Multifunctional regulators of vertebrate development. Genes Dev.
10:1580–1594. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Walsh DW, Godson C, Brazil DP and Martin
F: Extracellular BMP-antagonist regulation in development and
disease: Tied up in knots. Trends Cell Biol. 20:244–256. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Koosha E and Eames BF: Two modulators of
skeletal development: BMPs and Proteoglycans. J Dev Biol.
10:152022. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Miyazono K, Maeda S and Imamura T: BMP
receptor signaling: Transcriptional targets, regulation of signals,
and signaling cross-talk. Cytokine Growth Factor Rev. 16:251–263.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ogata T, Wozney JM, Benezra R and Noda M:
Bone morphogenetic protein 2 transiently enhances expression of a
gene, Id (inhibitor of differentiation), encoding a
helix-loop-helix molecule in osteoblast-like cells. Proc Natl Acad
Sci USA. 90:9219–9222. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Hollnagel A, Oehlmann V, Heymer J, Rüther
U and Nordheim A: Id genes are direct targets of bone morphogenetic
protein induction in embryonic stem cells. J Biol Chem.
274:19838–19845. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Borok MJ, Mademtzoglou D and Relaix F:
Bu-M-P-ing iron: How BMP signaling regulates muscle growth and
regeneration. J Dev Biol. 8:42020. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Korchynskyi O and Dijke PT: Identification
and functional characterization of distinct critically important
bone morphogenetic protein-specific response elements in the Id1
promoter. J Biol Chem. 277:4883–4891. 2002. View Article : Google Scholar
|
|
40
|
Shepherd TG, Thériault BL and Nachtigal
MW: Autocrine BMP4 signalling regulates ID3 proto-oncogene
expression in human ovarian cancer cells. Gene. 414:95–105. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Matsufuji S, Kitajima Y, Higure K, Kimura
N, Maeda S, Yamada K, Ito K, Tanaka T, Kai K and Noshiro H: A
HIF-1α inhibitor combined with palmitic acid and L-carnitine
treatment can prevent the fat metabolic reprogramming under hypoxia
and induce apoptosis in hepatocellular carcinoma cells. Cancer
Metab. 11:252023. View Article : Google Scholar
|
|
42
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
43
|
Reimann J, Brimah K, Schroder R, Wering A,
Beauchamp JR and Partridge TA: Pax7 distribution in human skeletal
muscle biopsies and myogenic tissue cultures. Cell Tissue Res.
315:233–242. 2004. View Article : Google Scholar
|
|
44
|
Borisov AB, Debkov EI and Carlson BM:
Differentiation of activated satellite cells in denervated muscle
following single fusions in situ and in cell culture. Histochem
Cell Biol. 124:13–23. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
He WA, Berardi E, Cardillo VM, Acharyya S,
Aulino P, Thomas-Ahner J, Wang J, Bloomston M, Muscarella P, Nau P,
et al: NF-κB-mediated Pax7 dysregulation in the muscle
microenvironment promotes cancer cachexia. J Clin Invest.
123:4821–4835. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Kleeff J, Maruyama H, Ishiwata T, Sawhney
H, Friess H, Büchler MW and Korc M: Bone morphogenetic protein 2
exerts diverse effects on cell growth in vitro and is expressed in
human pancreatic cancer in vivo. Gastroenterology. 116:1202–1216.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Aoki M, Ishigami S, Uenosono Y, Arigami T,
Uchikado Y, Kita Y, Kurahara H, Matsumoto M, Ueno S and Natsugoe S:
Expression of BMP-7 in human gastric cancer and its clinical
significance. B J Cancer. 104:714–718. 2011. View Article : Google Scholar
|
|
48
|
Guo X, Xiong L, Zou L and Zhao J:
Upregulation of bone morphogenetic protein 4 is associated with
poor prognosis in patients with hepatocellular carcinoma. Pathol
Oncol Res. 18:635–640. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Yokoyama Y, Watanabe T, Tamura Y,
Hashizume Y, Miyazono K and Ehata S: Autocrine BMP-4 signaling is a
therapeutic target in colorectal cancer. Cancer Res. 77:4026–4038.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Davis H, Raja E, Miyazono K, Thubakihara Y
and Moustakas A: Mechanism of action of bone morphogenetic proteins
in cancer. Cytokine Growth Factor Rev. 27:81–92. 2016. View Article : Google Scholar
|
|
51
|
Murre C, McCaw PS and Baltimore D: A new
DNA binding and dimerization motif in immunoglobulin enhancer
binding, daughterless, MyoD, and myc proteins. Cell. 56:777–783.
1989. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Davis RL, Cheng PF, Lassar AB and
Weintraub H: The MyoD DNA binding domain contains a recognition
code for muscle-specific gene activation. Cell. 60:733–746. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Ishibashi J, Perry RL, Asakura A and
Rudnicki MA: MyoD induces myogenic differentiation through
cooperation of its NH2- and COOH-terminal regions. J Cell Biol.
171:471–482. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Parker MH, Perry RLS, Fauteux MC, Berkes
CA and Rudnicki MA: MyoD synergizes with the E-protein HEB beta to
induce myogenic differentiation. Mol Cell Biol. 26:5771–5783. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Faralli H and Dilworth J: Turning on
myogenin in muscle: A paradigm for understanding mechanisms of
tissue-specific gene expression. Comp Funct Genomics.
2012:8363742012. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Berkes CA, Bergstrom DA, Penn BH, Seaver
KJ, Knoepfler PS and Tapscott SJ: Pbx marks genes for activation by
MyoD indicating a role for a homeodomain protein in establishing
myogenic potential. Mol Cell. 14:465–477. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Gerber AN, Klesert TR, Bergstrom DA and
Tapscott SJ: Two domains of MyoD mediate transcriptional activation
of genes in repressive chromatin: A mechanism for lineage
determination in myogenesis. Genes Dev. 11:436–450. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Lopez MA, Si Y, Hu X, Williams V, Qushair
F, Carlyle J, Alesce L, Conklin M, Gilbert S, Bamman MM, et al:
Smad8 is increased in duchenne muscular dystrophy and suppresses
miR-1, miR-133a, and miR-133b. Int J Mol Sci. 23:75152022.
View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Pasero M, Giovarelli M, Bucci G, Gherzi R
and Briata P: Bone morphogenetic protein/SMAD signaling orients
cell fate decision by impairing KSRP-dependent microRNA maturation.
Cell Rep. 2:1159–1168. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Jin W, Peng J and Jiang S: The epigenetic
regulation of embryonic myogenesis and adult muscle regeneration by
histone methylation modification. Biochem Biophys Rep. 6:209–219.
2016.PubMed/NCBI
|
|
61
|
Ono Y, Calhabeu F, Morgan JE, Katagiri T,
Amthor H and Zammit PS: BMP signalling permits population expansion
by preventing premature myogenic differentiation in muscle
satellite cells. Cell Death Differ. 18:222–234. 2011. View Article : Google Scholar :
|
|
62
|
Terada K, Misao S, Katase N, Nishimatsu S
and Nohno T: Interaction of Wnt signaling with BMP/Smad signaling
during the transition from cell proliferation to myogenic
differentiation in mouse myoblast-derived cells. Int J Cell Biol.
2013:6162942013. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Abrams KL, Xu J, Nativelle-Serpentini C,
Dabirshahsahebi S and Rogers MB: An Evolutionary and molecular
analysis of Bmp2 expression. J Biol Chem. 279:15916–15928. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Miyazono K, Kamiya Y and Morikawa M: Bone
morphogenetic protein receptors and signal transduction. J Biochem.
147:35–51. 2010. View Article : Google Scholar
|
|
65
|
Mueller TD and Nickel J: Promiscuity and
specificity in BMP receptor activation. FEBS Lett. 586:1846–1859.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Beppu H, Minowa O, Miyazono K and Kawabata
M: cDNA cloning and genomic organization of the mouse BMP type II
receptor. Biochem Biophys Res Commun. 235:499–504. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Nakane A, Nakagawa H and Nagata H:
Advanced high-content phenotypic screening to identify drugs that
ameliorate the inhibition of skeletal muscle cell differentiation
induced by cancer cachexia serum. Pharmaceuticals (Basel).
18:4452025. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Kosacka M, Dyła T, Chaszczewska-Markowska
M, Bogunia-Kubik K and Brzecka A: Decreased thrombospondin-1 and
bone morphogenetic protein-4 serum levels as potential indices of
advanced stage lung cancer. J Clin Med. 10:38592021. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Shi YJ and Pan XT: BMP6 and BMP4
expression in patients with cancer-related anemia and its
relationship with hepcidin and s-HJV. Gen Mol Res.
15:gmr.150171302015.
|
